Targeting Pim kinases in hematological cancers: molecular and clinical review

M Bellon, C Nicot - Molecular Cancer, 2023 - Springer
Decades of research has recognized a solid role for Pim kinases in lymphoproliferative
disorders. Often up-regulated following JAK/STAT and tyrosine kinase receptor signaling …

The PIM family of serine/threonine kinases in cancer

M Narlik‐Grassow, C Blanco‐Aparicio… - Medicinal research …, 2014 - Wiley Online Library
The proviral insertion site in Moloney murine leukemia virus, or PIM proteins, are a family of
serine/threonine kinases composed of three different isoforms (PIM1, PIM2, and PIM3) that …

Pim kinases in cancer: diagnostic, prognostic and treatment opportunities

C Blanco-Aparicio, A Carnero - Biochemical pharmacology, 2013 - Elsevier
PIM proteins belong to a family of ser/thr kinases composed of 3 members, PIM1, PIM2 and
PIM3, with greatly overlapping functions. PIM kinases are mainly responsible for cell cycle …

Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors

AKA Bass, ESM Nageeb, MS El-Zoghbi… - Bioorganic …, 2022 - Elsevier
Herein, we report design and synthesis of twenty-one dual PIM-1/HDAC inhibitors utilizing 3-
cyanopyridines as a novel cap moiety linked with aliphatic/aromatic linker bearing carboxylic …

Discovery of novel triazolo [4, 3-b] pyridazin-3-yl-quinoline derivatives as PIM inhibitors

S Martinez-Gonzalez, S Rodriguez-Aristegui… - European Journal of …, 2019 - Elsevier
Abstract PIM kinase family (PIM-1, PIM-2 and PIM-3) is an appealing target for the discovery
and development of selective inhibitors, useful in various disease conditions in which these …

HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells

SA Ganai, S Malli Kalladi… - Journal of Biomolecular …, 2015 - Taylor & Francis
Post-translational modifications on the tails of core and linker histones dictate transcription
and have vital roles in disease and development. Acetylation and deacetylation events …

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

E Martín-Sánchez, L Odqvist, SM Rodríguez-Pinilla… - PLoS …, 2014 - journals.plos.org
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL).
The Proviral Integration site of Moloney murine leukemia virus (PIM) kinases are important …

Novel agents in Hodgkin lymphoma

AJ Moskowitz - Current oncology reports, 2012 - Springer
Despite the success of modern therapy for Hodgkin lymphoma (HL), about 15% of patients
will fail both first-line and second-line therapy and treatment options for these patients are …

Inhibition of Pim–1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells

W Jie, QY He, BT Luo, SJ Zheng, YQ Kong… - Asian Pacific Journal of …, 2012 - Elsevier
OBJECTIVE: To explore the role of proto-oncogene Pim-1 in the proliferation and migration
of nasopharyngeal carcinoma (NPC) cells. METHODS: Pim-1 expressions in NPC cell lines …

Clinical development of panobinostat in classical Hodgkin's lymphoma

Y Oki, A Copeland, A Younes - Expert review of hematology, 2011 - Taylor & Francis
Deacetylase (DAC) inhibitors are promising new anticancer drugs that have complex
mechanisms of action, including induction of cell-cycle arrest and apoptosis, inhibition of …